Published online Sep 19, 2024. doi: 10.5498/wjp.v14.i9.1411
Revised: August 7, 2024
Accepted: August 13, 2024
Published online: September 19, 2024
Processing time: 173 Days and 15.2 Hours
Depression and metabolic syndrome could exacerbate the risks of the other, leading to a series of severe coexisting conditions. One notable comorbidity that must be mentioned is obstructive sleep apnea (OSA). Current studies suggested that depression increases susceptibility to OSA. As the prevalence of depression rises, it becomes critical to prevent and manage its complications or comorbidities, including OSA. Predictive models, non-invasive electroencephalogram moni
Core Tip: Depression and obstructive sleep apnea frequently coexist and share similar symptoms. By exploring the causal relationship between depression and obstructive sleep apnea, we may gain new insights and develop strategies for their prevention and treatment, contributing to improved overall health status for these patients and promoting the development of personalized treatment approaches.
- Citation: Wang X, Song SM, Yue HM. Burdened breaths: The influence of depression on obstructive sleep apnea. World J Psychiatry 2024; 14(9): 1411-1414
- URL: https://www.wjgnet.com/2220-3206/full/v14/i9/1411.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i9.1411
We read the retrospective cohort study published by Zhou et al[1] in the World Journal of Psychiatry in 2024. This study investigated the incidence and risk factors of depression among patients with metabolic syndrome (MetS). Subsequently, data from the 2-year, 4-year, and 7-year follow-up were analyzed to construct a predictive model for depression in patients with MetS. According to currently available studies, there is a strong relationship between depression and MetS. Zhou et al[1] described the causes and potential mechanisms associated with MetS and depression, and we believe that these results provide some insight into the causality of MetS and depression. However, the causality and direction of the two remains unclear due to the shortcomings of current observational study designs and the low feasibility of imple
Studies have shown that patients with depression were more likely to become obese or suffer from MetS due to lifestyle changes, sleep disorders, chronic inflammation, and the side effects of psychotropic medications[4,5]. Similarly, inflammation, imbalances in the neuroendocrine system, increased societal stress, poor lifestyle, and long-term medication render patients with MetS more susceptible to depression[6,7]. This suggests that the two conditions can exacerbate the risks of the other and lead to a series of severe coexisting diseases. One notable comorbidity that must be mentioned is obstructive sleep apnea (OSA)[8]. OSA is a common sleep disorder characterized by repeated episodes of upper airway collapse or obstruction, resulting in reduced or complete cessation of airflow during sleep[9]. OSA significantly affects sleep quality and physical health, leading to physical impairments and socioeconomic burdens. Long-term OSA increases the risk of heart disease, high blood pressure, and stroke[10,11].
Many studies have reported a strong association between depression and OSA, but most have focused on investigating the prevalence of depression among patients with OSA[12-16]. Using mendelian randomization analyses, our previously published study provided preliminary evidence that depression increases susceptibility to OSA[17]. Analyzing changes in nocturnal plasma levels of free fatty acids, glucose, and cortisol in patients with OSA, Chopra et al[18] found that patients with OSA and depression share increased sensitivity to corticotropin-releasing hormone, glucocorticoid resistance, and elevated cortisol levels due to similar hyperactivity of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system. Furthermore, both depression and OSA have been shown to be associated with chronic inflammation and are characterized by higher levels of proinflammatory cytokines such as tumor necrosis factor-alpha and interleukin-6[19,20].
Overall, the pathophysiological mechanisms of how depression contributes to OSA are not fully understood, but they may be related to several potential mechanisms as follows. Lifestyle and circadian rhythm changes could cause disruptions in sleep-wake rhythms, affecting the physiological balance of sleep and wake functions[21-23]. Depression is typically accompanied by hyperactivation of the hypothalamic-pituitary-adrenal axis; as adrenocorticotropic hormone secretion increases, patients may experience a decrease in slow-wave sleep duration and an increase in the average number of awakenings[24]. Moreover, impairment of the central and peripheral 5-hydroxytryptamine systems could affect airway patency. Reduced 5-hydroxytryptamine levels are thought to be one of the critical mechanisms leading to upper airway collapse and potentially to OSA[25].
As the prevalence of depression increases, it becomes critical to prevent and manage its complications or comorbidities such as OSA. Depression and OSA often coexist and exhibit similar symptoms, such as poor concentration, memory loss, mood swings, and unusual fatigue, which can complicate the clinical diagnosis of both conditions. Zhou et al[1] investigated the prevalence and risk factors of depression in patients with MetS and constructed predictive models through a large-sample cohort study. We believe this has significant implications, but there is no such model to predict the occurrence of OSA in depressed patients. For depressed patients, non-invasive electroencephalogram to detect susceptibility to OSA is a powerful tool[26]. Exploring the comorbidity and correlation between OSA and depression and understanding the prevalence in different populations could help identify high-risk groups and facilitate early intervention.
The treatment of OSA comorbid with depressive disorders involves various therapies for depression, including pharmacological and non-pharmacological interventions such as light therapy, sleep deprivation, and rhythm therapy. They have been shown to affect circadian rhythms. Oxidative stress and inflammation can also disrupt sleep architecture, contributing to dysfunctional sleep patterns[27]. As the first-line treatment for OSA, studies have shown that continuous positive airway pressure therapy could improve depressive symptoms in patients over the long term, despite the presence of high heterogeneity. As more and more promising technologies are applied to depression and OSA, there will be opportunities to enhance our understanding of them and other comorbidities. The potential mechanisms may provide new ideas and strategies for the prevention and treatment of OSA and depression and help improve the overall health of such patients. However, current evidence largely depends on cross-sectional clinical data and a limited number of experimental results, which challenges the assertion that depression explicitly causes OSA.
1. | Zhou LN, Ma XC, Wang W. Incidence and risk factors of depression in patients with metabolic syndrome. World J Psychiatry. 2024;14:245-254. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
2. | Repousi N, Masana MF, Sanchez-Niubo A, Haro JM, Tyrovolas S. Depression and metabolic syndrome in the older population: A review of evidence. J Affect Disord. 2018;237:56-64. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis (0)] |
3. | Dekker IP, Marijnissen RM, Giltay EJ, van der Mast RC, Oude Voshaar RC, Rhebergen D, Rius Ottenheim N. The role of metabolic syndrome in late-life depression over 6 years: The NESDO study. J Affect Disord. 2019;257:735-740. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis (0)] |
4. | Hiles SA, Révész D, Lamers F, Giltay E, Penninx BW. Bidirectional Prospective Associations of Metabolic Syndrome Components with Depression, Anxiety, And Antidepressant Use. Depress Anxiety. 2016;33:754-764. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 57] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis (0)] |
5. | Sekita A, Arima H, Ninomiya T, Ohara T, Doi Y, Hirakawa Y, Fukuhara M, Hata J, Yonemoto K, Ga Y, Kitazono T, Kanba S, Kiyohara Y. Elevated depressive symptoms in metabolic syndrome in a general population of Japanese men: a cross-sectional study. BMC Public Health. 2013;13:862. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
6. | García-Toro M, Vicens-Pons E, Gili M, Roca M, Serrano-Ripoll MJ, Vives M, Leiva A, Yáñez AM, Bennasar-Veny M, Oliván-Blázquez B. Obesity, metabolic syndrome and Mediterranean diet: Impact on depression outcome. J Affect Disord. 2016;194:105-108. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis (0)] |
7. | Moazzami K, Lima BB, Sullivan S, Shah A, Bremner JD, Vaccarino V. Independent and joint association of obesity and metabolic syndrome with depression and inflammation. Health Psychol. 2019;38:586-595. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis (0)] |
8. | Lv R, Liu X, Zhang Y, Dong N, Wang X, He Y, Yue H, Yin Q. Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome. Signal Transduct Target Ther. 2023;8:218. [PubMed] [DOI] [Cited in This Article: ] [Cited by in F6Publishing: 46] [Reference Citation Analysis (0)] |
9. | Lévy P, Kohler M, McNicholas WT, Barbé F, McEvoy RD, Somers VK, Lavie L, Pépin JL. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1:15015. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 452] [Cited by in F6Publishing: 586] [Article Influence: 65.1] [Reference Citation Analysis (0)] |
10. | Sabil A, Gagnadoux F. Obstructive sleep apnoea, nocturnal hypoxaemia, and cognitive decline in elderly patients. Eur Respir J. 2023;61. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
11. | Martinez-Garcia MA, Campos-Rodriguez F, Gozal D. Obstructive sleep apnoea in acute coronary syndrome. Lancet Respir Med. 2020;8:e15. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis (0)] |
12. | Fang H, Tu S, Sheng J, Shao A. Depression in sleep disturbance: A review on a bidirectional relationship, mechanisms and treatment. J Cell Mol Med. 2019;23:2324-2332. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 233] [Cited by in F6Publishing: 503] [Article Influence: 100.6] [Reference Citation Analysis (0)] |
13. | Gleeson M, McNicholas WT. Bidirectional relationships of comorbidity with obstructive sleep apnoea. Eur Respir Rev. 2022;31. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 2] [Cited by in F6Publishing: 58] [Article Influence: 29.0] [Reference Citation Analysis (0)] |
14. | Chen YH, Keller JK, Kang JH, Hsieh HJ, Lin HC. Obstructive sleep apnea and the subsequent risk of depressive disorder: a population-based follow-up study. J Clin Sleep Med. 2013;9:417-423. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 73] [Cited by in F6Publishing: 98] [Article Influence: 8.9] [Reference Citation Analysis (0)] |
15. | Lu MK, Tan HP, Tsai IN, Huang LC, Liao XM, Lin SH. Sleep apnea is associated with an increased risk of mood disorders: a population-based cohort study. Sleep Breath. 2017;21:243-253. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis (0)] |
16. | Lee SA, Paek JH, Han SH. REM-related sleep-disordered breathing is associated with depressive symptoms in men but not in women. Sleep Breath. 2016;20:995-1002. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis (0)] |
17. | Wang X, Song S, Dong N, Lv R, He Y, Zhao Y, Yue H. The causal relationship between depression and obstructive sleep apnea: A bidirectional Mendelian randomization study. J Psychosom Res. 2024;179:111620. [PubMed] [DOI] [Cited in This Article: ] [Reference Citation Analysis (0)] |
18. | Chopra S, Rathore A, Younas H, Pham LV, Gu C, Beselman A, Kim IY, Wolfe RR, Perin J, Polotsky VY, Jun JC. Obstructive Sleep Apnea Dynamically Increases Nocturnal Plasma Free Fatty Acids, Glucose, and Cortisol During Sleep. J Clin Endocrinol Metab. 2017;102:3172-3181. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 82] [Cited by in F6Publishing: 88] [Article Influence: 12.6] [Reference Citation Analysis (0)] |
19. | Gaines J, Vgontzas AN, Fernandez-Mendoza J, Kritikou I, Basta M, Bixler EO. Gender differences in the association of sleep apnea and inflammation. Brain Behav Immun. 2015;47:211-217. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis (0)] |
20. | Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21:1696-1709. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 926] [Cited by in F6Publishing: 1096] [Article Influence: 137.0] [Reference Citation Analysis (0)] |
21. | Gupta MA, Simpson FC, Lyons DC. The effect of treating obstructive sleep apnea with positive airway pressure on depression and other subjective symptoms: A systematic review and meta-analysis. Sleep Med Rev. 2016;28:55-68. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 69] [Cited by in F6Publishing: 77] [Article Influence: 9.6] [Reference Citation Analysis (0)] |
22. | Holma IA, Holma KM, Melartin TK, Ketokivi M, Isometsä ET. Depression and smoking: a 5-year prospective study of patients with major depressive disorder. Depress Anxiety. 2013;30:580-588. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis (0)] |
23. | Pandi-Perumal SR, Monti JM, Burman D, Karthikeyan R, BaHammam AS, Spence DW, Brown GM, Narashimhan M. Clarifying the role of sleep in depression: A narrative review. Psychiatry Res. 2020;291:113239. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 57] [Cited by in F6Publishing: 122] [Article Influence: 30.5] [Reference Citation Analysis (0)] |
24. | Eser D, Schüle C, Romeo E, Baghai TC, di Michele F, Pasini A, Zwanzger P, Padberg F, Rupprecht R. Neuropsychopharmacological properties of neuroactive steroids in depression and anxiety disorders. Psychopharmacology (Berl). 2006;186:373-387. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis (0)] |
25. | Liu C, Meng Z, Wiggin TD, Yu J, Reed ML, Guo F, Zhang Y, Rosbash M, Griffith LC. A Serotonin-Modulated Circuit Controls Sleep Architecture to Regulate Cognitive Function Independent of Total Sleep in Drosophila. Curr Biol. 2019;29:3635-3646.e5. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis (0)] |
26. | de Aguiar Neto FS, Rosa JLG. Depression biomarkers using non-invasive EEG: A review. Neurosci Biobehav Rev. 2019;105:83-93. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 83] [Cited by in F6Publishing: 88] [Article Influence: 17.6] [Reference Citation Analysis (0)] |
27. | Farney RJ, Lugo A, Jensen RL, Walker JM, Cloward TV. Simultaneous use of antidepressant and antihypertensive medications increases likelihood of diagnosis of obstructive sleep apnea syndrome. Chest. 2004;125:1279-1285. [PubMed] [DOI] [Cited in This Article: ] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis (0)] |